CymitQuimica logo

CAS 1097263-60-9

:

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 prodotti.
  • Bosentan Related Compound C (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane)

    CAS:
    <p>Sulfonamides, nesoi</p>
    Formula:C52H52N10O10S2
    Colore e forma:Off-White Powder
    Peso molecolare:1040.33093
  • Bosentan USP Related Compound C

    CAS:
    Formula:C52H52N10O10S2
    Colore e forma:Pale Yellow Solid
    Peso molecolare:1041.17

    Ref: 4Z-B-1210

    5mg
    Prezzo su richiesta
    10mg
    910,00€
    25mg
    1.638,00€
    50mg
    2.366,00€
    100mg
    Prezzo su richiesta
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide

    Prodotto controllato
    CAS:
    <p>Impurity Bosentan USP Related Compound C<br>Applications N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide is an impurity of Bosentan (B675900), a mixed endothelin receptor antagonist. Bosentan USP Related Compound C.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994), Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996), Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996), Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>
    Formula:C52H52N10O10S2
    Colore e forma:Neat
    Peso molecolare:1041.16

    Ref: TR-E676300

    10mg
    1.530,00€
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4

    Prodotto controllato
    CAS:
    <p>Applications N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4 is labelled N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide (E676300) which is an impurity of Bosentan (B675900), a mixed endothelin receptor antagonist.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994), Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996), Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996), Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>
    Formula:C52D4H48N10O10S2
    Colore e forma:Neat
    Peso molecolare:1045.185

    Ref: TR-E676302

    5mg
    1.530,00€
  • Bosentan impurity C

    CAS:
    <p>Bosentan impurity C is a stable crystalline compound that is soluble in organic solvents. It has been identified as an impurity of the drug bosentan, and has been found to be present in the drug at concentrations of up to 0.2%. Bosentan impurity C can be prepared by crystallization from an alkaline solution and can also be obtained as a salt form. The salt form is a dimer that consists of two bosentan molecules linked together by one oxygen atom. Bosentan impurity C is stable under normal conditions and does not undergo any changes when exposed to light or heat. This compound has shown no significant adverse effects on humans who have taken it, with no adverse effects on the kidney, liver, or lungs reported.</p>
    Formula:C52H52N10O10S2
    Purezza:Min. 95%
    Peso molecolare:1,041.16 g/mol

    Ref: 3D-IB64076

    50mg
    3.293,00€
    100mg
    5.185,00€
  • Bosentan USP Related Compound C

    CAS:
    Formula:C52H52N10O10S2
    Peso molecolare:1041.17

    Ref: ST-EA-CP-B59004

    10mg
    Prezzo su richiesta
    25mg
    Prezzo su richiesta
    50mg
    Prezzo su richiesta
    100mg
    Prezzo su richiesta